Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Pelvic Fracture Healing
NCT02972424Phase 2Completed
- Sponsor
- Hospital for Special Surgery
- Start
- May 2017
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of teriparatide in Osteoporotic fracture, sponsored by Hospital for Special Surgery. Primary endpoint: Number of Participants With Evidence of Cortical Bridging at 3 months. Started May 2017; status: completed.
02
Drugs
teriparatide
03
Conditions
Osteoporotic fracture
Beyond the preview
Go deeper on NCT02972424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972424.